Literature DB >> 7934541

Role of factor XII in thrombin generation and fibrinolysis during cardiopulmonary bypass.

J F Burman1, H I Chung, D A Lane, H Philippou, A Adami, J C Lincoln.   

Abstract

During cardiopulmonary bypass, thrombin is generated, which is thought to be initiated by activation of factor XII on the surface of the bypass equipment. We present a patient with severe factor XII deficiency who underwent cardiac surgery. As much thrombin was formed during cardiopulmonary bypass (measured by the prothrombin activation fragment F1 + 2 and thrombin-antithrombin complexes) as in normal patients, showing that factor XII was not necessary for thrombin generation. Factor X, but not factor IX, was activated (as measured by their activation peptides), and this activation correlated with F1 + 2 and thrombin-antithrombin complexes, suggesting that the tissue-factor/factor-VIIa pathway is the trigger for thrombin formation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7934541     DOI: 10.1016/s0140-6736(94)90509-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  16 in total

Review 1.  The hemostatic defect of cardiopulmonary bypass.

Authors:  Matthew Dean Linden
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

Review 2.  Coagulation and fibrinolytic protein kinetics in cardiopulmonary bypass.

Authors:  Maryam Yavari; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2008-01-23       Impact factor: 2.300

3.  Anticoagulant therapy during cardiopulmonary bypass.

Authors:  Maryam Yavari; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2008-10-19       Impact factor: 2.300

4.  Probing the coagulation pathway with aptamers identifies combinations that synergistically inhibit blood clot formation.

Authors:  Kristin M Bompiani; Jens L Lohrmann; George A Pitoc; James W Frederiksen; George B Mackensen; Bruce A Sullenger
Journal:  Chem Biol       Date:  2014-07-24

5.  Hemostatic response in paediatric patients undergoing cardiopulmonary bypass surgery.

Authors:  Vera Ignjatovic; Jenny Than; Robyn Summerhayes; Fiona Newall; Stephen Horton; Andrew Cochrane; Paul Monagle
Journal:  Pediatr Cardiol       Date:  2011-03-01       Impact factor: 1.655

Review 6.  Cardiopulmonary bypass in patients with pre-existing coagulopathy.

Authors:  William DeBois; Junli Liu; Leonard Lee; Leonard Girardi; Wilson Ko; Anthony Tortolani; Karl Krieger; O Wayne Isom
Journal:  J Extra Corpor Technol       Date:  2005-03

7.  Factor XII Deficiency and Cardiopulmonary Bypass.

Authors:  Victor Uppal; Mark Rosin
Journal:  J Extra Corpor Technol       Date:  2014-09

Review 8.  Coagulation disorders of cardiopulmonary bypass: a review.

Authors:  Domenico Paparella; Stephanie J Brister; Michael R Buchanan
Journal:  Intensive Care Med       Date:  2004-07-24       Impact factor: 17.440

Review 9.  Inhibition of Factors XI and XII for Prevention of Thrombosis Induced by Artificial Surfaces.

Authors:  Benjamin Tillman; David Gailani
Journal:  Semin Thromb Hemost       Date:  2017-09-12       Impact factor: 4.180

10.  Heparin anticoagulation in patients undergoing off-pump and on-pump coronary bypass surgery.

Authors:  Kenichi A Tanaka; Vinod H Thourani; Willis H Williams; Peggy G Duke; Jerrold H Levy; Robert A Guyton; John D Puskas
Journal:  J Anesth       Date:  2007-08-01       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.